Newly published research contradicts earlier findings about pubic hair grooming as a risk factor for sexually transmitted infection (STI).
©vladimirfloyd - stock.adobe.com
Newly published research in PLOS One contradicts earlier findings about pubic hair grooming as a risk factor for sexually transmitted infection (STI). Earlier studies suggested an association between the practice and higher STI rates, but that might not be the case, at least in young, wealthier, white women.
The study objective was to evaluate the association between self-reported extreme grooming and laboratory-confirmed prevalence of gonorrhea and Chlamydia trachomatis (GC/CT) among female university students. The participants, who presented at one of two walk-in STI testing sites on the campus of a large university from April 2017 to April 2018, completed a questionnaire on demographics, sexual behavior, STI risk factors and pubic hair grooming.
Extreme grooming was defined as removal of pubic hair either at least weekly in the past 12 months or ≥ 6 times in the past 30 days. The authors also used two logistic regression models to determine whether odds of GC/CT varied by extreme groomer status for either time interval.
Prevalence of GC/CT was 9.8% among the 214 women in the study. Most of them were white (75.2%), single (72.0%) and reported a parental or guardian income of $60,000 or higher. Almost all of the participants who reported ever grooming (98.1%), 53.6% were extreme groomers in the past year and 18% in the past month. Nearly two-thirds (63.3%) had experienced a grooming injury, and the mean number of lifetime grooming injuries was 4.9 (SD = 3.8).
In both unadjusted and adjusted models, the authors found no difference in the odds of GC/CT between women who were extreme groomers within the past 12 months and those who were not extreme groomers (OR=0.8, 95% CI 0.3-1.9; adjusted OR = 0.6, 95% CI 0.3-2.0, respectively). Unadjusted and adjusted associations between extreme grooming within the past month and prevalent GC/CT were slightly stronger but were still non-significant (unadjusted OR = 0.5, 95% CI = 0.1-2.0; adjusted OR = 0.4, 95% CI 0.1-1.9).
Although these findings conflict with the results of earlier studies, the authors note that this study was limited by its population, both in terms of the number of participants and their homogeneity. Still, the authors believe their finding do not support the need for public health or clinical interventions to address pubic hair grooming as a risk factor for GC or CT. Future studies should focus on using a larger, more representative sample, the researchers said, to gather more precise estimates and wider generalizability.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
Trends in STI prevalence and testing guidelines
April 11th 2024In a recent interview, Cheruba Prabakar, MD, FACOG, shed light on the rising prevalence of sexually transmitted infections in the United States and the need for improved awareness and testing, particularly for overlooked conditions such as trichomoniasis.
Read More
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
Read More
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Read More